←Back to Expert Scholars
Translational Medicine / 转化医学Ovarian Cancer Early Detection, Population Genetic Testing
Ranjit Manchanda
MD, PhD
🏢Queen Mary University of London / Barts Cancer Institute🌐UK
Professor of Gynaecological Oncology
60
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Ranjit Manchanda is a leader in population-level BRCA testing and risk-reducing surgery for ovarian cancer prevention. His work has shown cost-effectiveness of expanded BRCA testing beyond family-history-based criteria. He leads gynecologic oncology research at Barts.
Share:
🧪Research Fields 研究领域
population BRCA testing
risk-reducing surgery
cost-effectiveness
Jewish BRCA testing
prevention
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Ranjit Manchanda 的研究动态
Follow Ranjit Manchanda's research updates
留下邮箱，当我们发布与 Ranjit Manchanda（Queen Mary University of London / Barts Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment